[{"Assets_0_Q1_USD":"13933160000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"32.77","EarningsPerShareDiluted_1_Q1_USD":"32.38","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"113610000.0","NetIncomeLossConverted_1_Q1_USD":"977414000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q1_USD":"726796000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q1_USD":"10609059000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"30186000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"29823000.0","filed":"20210430","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"BIO-RAD LABORATORIES, INC.","period":"20210331","qtrs":"1","uom":"USD"}]